BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9860927)

  • 1. The aryl hydrocarbon receptor: studies using the AHR-null mice.
    Gonzalez FJ; Fernandez-Salguero P
    Drug Metab Dispos; 1998 Dec; 26(12):1194-8. PubMed ID: 9860927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel role for the dioxin receptor in fatty acid metabolism and hepatic steatosis.
    Lee JH; Wada T; Febbraio M; He J; Matsubara T; Lee MJ; Gonzalez FJ; Xie W
    Gastroenterology; 2010 Aug; 139(2):653-63. PubMed ID: 20303349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AOP Report: Aryl Hydrocarbon Receptor Activation Leads to Early-Life Stage Mortality via Sox9 Repression-Induced Craniofacial and Cardiac Malformations.
    Shankar P; Villeneuve DL
    Environ Toxicol Chem; 2023 Oct; 42(10):2063-2077. PubMed ID: 37341548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AHR2 required for normal behavioral responses and proper development of the skeletal and reproductive systems in zebrafish.
    Garcia GR; Bugel SM; Truong L; Spagnoli S; Tanguay RL
    PLoS One; 2018; 13(3):e0193484. PubMed ID: 29494622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Aryl Hydrocarbon Receptor in Energy Balance: The Road from Dioxin-Induced Wasting Syndrome to Combating Obesity with Ahr Ligands.
    Girer NG; Tomlinson CR; Elferink CJ
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting aryl hydrocarbon receptor to prevent cancer in barrier organs.
    Congues F; Wang P; Lee J; Lin D; Shahid A; Xie J; Huang Y
    Biochem Pharmacol; 2024 May; 223():116156. PubMed ID: 38518996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target.
    Safe S; Lee SO; Jin UH
    Toxicol Sci; 2013 Sep; 135(1):1-16. PubMed ID: 23771949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to Environmental Toxins: Potential Implications for Stroke Risk via the Gut- and Lung-Brain Axis.
    Ruggles A; Benakis C
    Cells; 2024 May; 13(10):. PubMed ID: 38786027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aryl Hydrocarbon Receptor (AhR) Signaling in Colonic Cells and Tumors.
    Safe S; Han H; Jayaraman A; Davidson LA; Allred CD; Ivanov I; Yang Y; Cai JJ; Chapkin RS
    Receptors (Basel); 2023 Mar; 2(1):93-99. PubMed ID: 38651159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Aryl Hydrocarbon Receptor: Impact on the Tumor Immune Microenvironment and Modulation as a Potential Therapy.
    Griffith BD; Frankel TL
    Cancers (Basel); 2024 Jan; 16(3):. PubMed ID: 38339226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrete interplay of gut microbiota L-tryptophan metabolites in host biology and disease.
    Ranhotra HS
    Mol Cell Biochem; 2023 Oct; ():. PubMed ID: 37861881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Basic concepts of mixture toxicity and relevance for risk evaluation and regulation.
    Bloch D; Diel P; Epe B; Hellwig M; Lampen A; Mally A; Marko D; Villar Fernández MA; Guth S; Roth A; Marchan R; Ghallab A; Cadenas C; Nell P; Vartak N; van Thriel C; Luch A; Schmeisser S; Herzler M; Landsiedel R; Leist M; Marx-Stoelting P; Tralau T; Hengstler JG
    Arch Toxicol; 2023 Nov; 97(11):3005-3017. PubMed ID: 37615677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AhR agonist tapinarof ameliorates lupus autoimmunity by suppressing Tfh cell differentiation via regulation of the JAK2-STAT3 signaling pathway.
    Zhang Y; Pan Y; Zhang P; Wang F; Han Y; Li K; Jiang W; Wang J; Luan Y; Xin Q
    Immun Inflamm Dis; 2023 Jun; 11(6):e903. PubMed ID: 37382269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-Suppressive Functions of the Aryl Hydrocarbon Receptor (AhR) and AhR as a Therapeutic Target in Cancer.
    Elson DJ; Kolluri SK
    Biology (Basel); 2023 Mar; 12(4):. PubMed ID: 37106727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of the Aryl Hydrocarbon Receptor (AhR) and Its Ligands in Breast Cancer.
    Safe S; Zhang L
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Aryl Hydrocarbon Receptor (AhR) Expression Disrupts Cell Proliferation and Alters Energy Metabolism and Fatty Acid Synthesis in Colon Cancer Cells.
    Karasová M; Procházková J; Tylichová Z; Fedr R; Ciganek M; Machala M; Dvořák Z; Vyhlídalová B; Zůvalová I; Ehrmann J; Bouchal J; Andrysík Z; Vondráček J
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCB126 induced toxic actions on liver energy metabolism is mediated by AhR in rats.
    Eti NA; Flor S; Iqbal K; Scott RL; Klenov VE; Gibson-Corley KN; Soares MJ; Ludewig G; Robertson LW
    Toxicology; 2022 Jan; 466():153054. PubMed ID: 34848246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino Acid Trp: The Far Out Impacts of Host and Commensal Tryptophan Metabolism.
    Grifka-Walk HM; Jenkins BR; Kominsky DJ
    Front Immunol; 2021; 12():653208. PubMed ID: 34149693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Aryl Hydrocarbon Receptor Undergoes Chaperone-Mediated Autophagy in Triple-Negative Breast Cancer Cells.
    Chen J; Yang Y; Russu WA; Chan WK
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aryl Hydrocarbon Receptor (AHR) Ligands as Selective AHR Modulators (SAhRMs).
    Safe S; Jin UH; Park H; Chapkin RS; Jayaraman A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932962
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.